{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:20:40Z","timestamp":1790900440991,"version":"4.1.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T00:00:00Z","timestamp":1581379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T00:00:00Z","timestamp":1581379200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"This research was funded by the Deanship of Scientific Research at Princess Nourah bint Abdulrahman University through the Fast-track Research Funding Program.","award":["This research was funded by the Deanship of Scientific Research at Princess Nourah bint Abdulrahman University through the Fast-track Research Funding Program."],"award-info":[{"award-number":["This research was funded by the Deanship of Scientific Research at Princess Nourah bint Abdulrahman University through the Fast-track Research Funding Program."]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s10637-020-00905-6","type":"journal-article","created":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T04:07:58Z","timestamp":1581394078000},"page":"1303-1315","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Combating atherosclerosis with targeted Diosmin nanoparticles-treated experimental diabetes"],"prefix":"10.1007","volume":"38","author":[{"given":"Hendawy","family":"OM","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrez E.","family":"El-Naggar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"El-Banna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moustafa M. G.","family":"Fouda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah I.","family":"Othman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed A.","family":"Allam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama M.","family":"Morsy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,11]]},"reference":[{"key":"905_CR1","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1600-0757.2012.00455.x","volume":"64","author":"P Bullon","year":"2000","unstructured":"Bullon P, Newman HN (2000) Battino M (2014) obesity, diabetes mellitus, atherosclerosis and chronic periodontitis: a shared pathology via oxidative stress and mitochondrial dysfunction? Periodontol 64:139\u2013153","journal-title":"Periodontol"},{"key":"905_CR2","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1056\/NEJMoa1408214","volume":"371","author":"M Lind","year":"2014","unstructured":"Lind M, Svensson A-M, Kosiborod M et al (2014) Glycemic control and excess mortality in type 1 diabetes. N Engl J Med 371:1972\u20131982","journal-title":"N Engl J Med"},{"key":"905_CR3","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1007\/s00125-015-3637-1","volume":"58","author":"RH Al-Mashhadi","year":"2015","unstructured":"Al-Mashhadi RH, Bj\u00f8rklund MM, Mortensen MB et al (2015) Diabetes with poor glycaemic control does not promote atherosclerosis in genetically modified hypercholesterolaemic minipigs. Diabetologia 58:1926\u20131936","journal-title":"Diabetologia"},{"key":"905_CR4","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1194\/jlr.R200004-JLR200","volume":"43","author":"KK Berneis","year":"2002","unstructured":"Berneis KK, Krauss RM (2002) Metabolic origins and clinical significance of LDL heterogeneity. J Lipid Res 43:1363\u20131379","journal-title":"J Lipid Res"},{"key":"905_CR5","unstructured":"Katakami N (2017) Mechanism of development of atherosclerosis and cardiovascular disease in diabetes mellitus. J Atheroscler Thromb:RV17014"},{"key":"905_CR6","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S1056-8727(00)00132-X","volume":"15","author":"ME Carr","year":"2001","unstructured":"Carr ME (2001) Diabetes mellitus: a hypercoagulable state. J Diabetes Complicat 15:44\u201354","journal-title":"J Diabetes Complicat"},{"key":"905_CR7","first-page":"3527","volume":"91","author":"DB Cines","year":"1998","unstructured":"Cines DB, Pollak ES, Buck CA et al (1998) Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 91:3527\u20133561","journal-title":"Blood"},{"key":"905_CR8","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/00045415-200109000-00003","volume":"9","author":"S VERMA","year":"2001","unstructured":"VERMA S, ANDERSON TJ (2001) The ten most commonly asked questions about endothelial function in cardiology. Cardiol Rev 9:250\u2013252","journal-title":"Cardiol Rev"},{"key":"905_CR9","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1001\/jama.287.19.2570","volume":"287","author":"JA Beckman","year":"2002","unstructured":"Beckman JA, Creager MA, Libby P (2002) Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. Jama 287:2570\u20132581","journal-title":"Jama"},{"key":"905_CR10","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s11883-000-0082-4","volume":"2","author":"AM Schmidt","year":"2000","unstructured":"Schmidt AM, Stern D (2000) Atherosclerosis and diabetes: the RAGE connection. Curr Atheroscler Rep 2:430\u2013436","journal-title":"Curr Atheroscler Rep"},{"key":"905_CR11","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/sj.clpt.6100400","volume":"83","author":"L Zhang","year":"2008","unstructured":"Zhang L, Gu FX, Chan JM et al (2008) Nanoparticles in medicine: therapeutic applications and developments. Clin Pharmacol Ther 83:761\u2013769","journal-title":"Clin Pharmacol Ther"},{"key":"905_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-3659(00)00339-4","volume":"70","author":"KS Soppimath","year":"2001","unstructured":"Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE (2001) Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release 70:1\u201320","journal-title":"J Control Release"},{"key":"905_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2015.09.001","volume":"102","author":"F Imam","year":"2015","unstructured":"Imam F, Al-Harbi NO, Al-Harbi MM et al (2015) Diosmin downregulates the expression of T cell receptors, pro-inflammatory cytokines and NF-\u03baB activation against LPS-induced acute lung injury in mice. Pharmacol Res 102:1\u201311","journal-title":"Pharmacol Res"},{"key":"905_CR14","doi-asserted-by":"crossref","unstructured":"Feldo M, Wo\u017aniak M, W\u00f3jciak-Kosior M et al (2018) Influence of diosmin treatment on the level of oxidative stress markers in patients with chronic venous insufficiency. Oxid Med Cell Longev 2018","DOI":"10.1155\/2018\/2561705"},{"key":"905_CR15","first-page":"2015","volume":"3","author":"MK Anwer","year":"2014","unstructured":"Anwer MK (2014) Development of diosmin loaded eudragit s100 polymeric nanoparticles: an investigation of antioxidant effect. IJBPAS 3:2015\u20132026","journal-title":"IJBPAS"},{"key":"905_CR16","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1108\/RJTA-17-03-2013-B009","volume":"17","author":"A Hebeish","year":"2013","unstructured":"Hebeish A, El-Rafie MH, Ramadan MA, El-Naggar ME (2013) Investigation into the synthesis and characterization of silver nanoparticles. Res J Text Appar 17:83\u201397. https:\/\/doi.org\/10.1108\/RJTA-17-03-2013-B009","journal-title":"Res J Text Appar"},{"key":"905_CR17","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1093\/jn\/134.3.600","volume":"134","author":"R Kohli","year":"2004","unstructured":"Kohli R, Meininger CJ, Haynes TE et al (2004) Dietary L-arginine supplementation enhances endothelial nitric oxide synthesis in streptozotocin-induced diabetic rats. J Nutr 134:600\u2013608","journal-title":"J Nutr"},{"key":"905_CR18","doi-asserted-by":"crossref","first-page":"e0122417","DOI":"10.1371\/journal.pone.0122417","volume":"10","author":"HH Arab","year":"2015","unstructured":"Arab HH, Salama SA, Omar HA et al (2015) Diosmin protects against ethanol-induced gastric injury in rats: novel anti-ulcer actions. PLoS One 10:e0122417","journal-title":"PLoS One"},{"key":"905_CR19","first-page":"689","volume":"60","author":"F Mannaa","year":"2005","unstructured":"Mannaa F, Ahmed HH, Estefan SF et al (2005) Saccharomyces cerevisiae intervention for relieving flutamide-induced hepatotoxicity in male rats. Die Pharm Int J Pharm Sci 60:689\u2013695","journal-title":"Die Pharm Int J Pharm Sci"},{"key":"905_CR20","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1210\/jcem-55-2-321","volume":"55","author":"RG JUDZEWITSCH","year":"1982","unstructured":"JUDZEWITSCH RG, PFEIFER MA, BEST JD et al (1982) Chronic chlorpropamide therapy of noninsulin-dependent diabetes augments basal and stimulated insulin secretion by increasing islet sensitivity to glucose. J Clin Endocrinol Metab 55:321\u2013328","journal-title":"J Clin Endocrinol Metab"},{"key":"905_CR21","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1093\/clinchem\/19.12.1350","volume":"19","author":"W Richmond","year":"1973","unstructured":"Richmond W (1973) Preparation and properties of a cholesterol oxidase from Nocardia sp. and its application to the enzymatic assay of total cholesterol in serum. Clin Chem 19:1350\u20131356","journal-title":"Clin Chem"},{"key":"905_CR22","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1093\/clinchem\/28.10.2077","volume":"28","author":"P Fossati","year":"1982","unstructured":"Fossati P, Prencipe L (1982) Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem 28:2077\u20132080","journal-title":"Clin Chem"},{"key":"905_CR23","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/clinchem\/23.5.882","volume":"23","author":"MF Lopes-Virella","year":"1977","unstructured":"Lopes-Virella MF, Stone P, Ellis S, Colwell JA (1977) Cholesterol determination in high-density lipoproteins separated by three different methods. Clin Chem 23:882\u2013884","journal-title":"Clin Chem"},{"key":"905_CR24","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/00325481.1984.11698776","volume":"76","author":"TR Glatter","year":"1984","unstructured":"Glatter TR (1984) Hyperlipidemia: What is \u2018normal,\u2018who should be treated and how. Postgrad Med 76:49\u201359","journal-title":"Postgrad Med"},{"key":"905_CR25","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0039-128X(94)90006-X","volume":"59","author":"MB Ruiz-Larrea","year":"1994","unstructured":"Ruiz-Larrea MB, Leal AM, Liza M et al (1994) Antioxidant effects of estradiol and 2-hydroxyestradiol on iron-induced lipid peroxidation of rat liver microsomes. Steroids 59:383\u2013388","journal-title":"Steroids"},{"key":"905_CR26","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","volume":"82","author":"Ellman","year":"1959","unstructured":"Ellman (1959) GL. Tissue sulfhydryl groups. Arch Biochem Biophys 82:70\u201377","journal-title":"Arch Biochem Biophys"},{"key":"905_CR27","first-page":"124","volume":"3","author":"J Hussein","year":"2013","unstructured":"Hussein J, Refaat E, Morsy S et al (2013) Green tea attenuates experimental hepatitis in context of oxidative stress. J Appl Pharm Sci 3:124","journal-title":"J Appl Pharm Sci"},{"key":"905_CR28","first-page":"38","volume":"5","author":"NA Mohamed","year":"2018","unstructured":"Mohamed NA, El-Naggar ME (2018) Amifostine-based nanoemulsion as promising protective agent for nephrotoxicity. J Innov Pharm Biol Sci 5:38\u201345","journal-title":"J Innov Pharm Biol Sci"},{"key":"905_CR29","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1007\/s00580-019-02990-3","volume":"28","author":"J Hussein","year":"2019","unstructured":"Hussein J, El-Naggar ME, Anwar M et al (2019) Synthesis of docosahexaenoic acid\u2013loaded zinc oxide nanoparticles as a promising treatment in neurotoxicity. Comp Clin Pathol 28:1455\u20131464. https:\/\/doi.org\/10.1007\/s00580-019-02990-3","journal-title":"Comp Clin Pathol"},{"key":"905_CR30","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1177\/0960327119843586","volume":"38","author":"JS Hussein","year":"2019","unstructured":"Hussein JS, Rasheed W, Ramzy T et al (2019) Synthesis of docosahexaenoic acid\u2013loaded silver nanoparticles for improving endothelial dysfunctions in experimental diabetes. Hum Exp Toxicol 38:962\u2013973. https:\/\/doi.org\/10.1177\/0960327119843586","journal-title":"Hum Exp Toxicol"},{"key":"905_CR31","doi-asserted-by":"publisher","unstructured":"Hamad SR, El-Naggar ME (2019) Blocking of gastric acid induced histopathological alterations, enhancing of DNA content and proliferation of goblet cells in the acute lung injury mice models by nano-fenugreek oral administration. Toxicol Mech Methods. https:\/\/doi.org\/10.1080\/15376516.2019.1669249","DOI":"10.1080\/15376516.2019.1669249"},{"key":"905_CR32","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.colsurfb.2019.02.024","volume":"177","author":"ME El-Naggar","year":"2019","unstructured":"El-Naggar ME, Al-Joufi F, Anwar M et al (2019) Curcumin-loaded PLA-PEG copolymer nanoparticles for treatment of liver inflammation in streptozotocin-induced diabetic rats. Colloids Surf B: Biointerfaces 177:389\u2013398. https:\/\/doi.org\/10.1016\/j.colsurfb.2019.02.024","journal-title":"Colloids Surf B: Biointerfaces"},{"key":"905_CR33","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.ijbiomac.2015.09.005","volume":"81","author":"ME El-Naggar","year":"2015","unstructured":"El-Naggar ME, El-Rafie MH, El-sheikh MA et al (2015) Synthesis, characterization, release kinetics and toxicity profile of drug-loaded starch nanoparticles. Int J Biol Macromol 81:718\u2013729. https:\/\/doi.org\/10.1016\/j.ijbiomac.2015.09.005","journal-title":"Int J Biol Macromol"},{"key":"905_CR34","first-page":"254","volume":"6","author":"GS El-Feky","year":"2015","unstructured":"El-Feky GS, E-R MH, El-Sheikh MA et al (2015) Utilization of Crosslinked starch nanoparticles as a carrier for indomethacin and acyclovir drugs. Nanomedicine Nanotechnol 6:254","journal-title":"Nanomedicine Nanotechnol"},{"key":"905_CR35","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.biopha.2016.07.052","volume":"83","author":"TI Shaheen","year":"2016","unstructured":"Shaheen TI, El-Naggar ME, Hussein JS et al (2016) Antidiabetic assessment; in vivo study of gold and core-shell silver-gold nanoparticles on streptozotocin-induced diabetic rats. Biomed Pharmacother Biomed Pharmacother 83:865","journal-title":"Biomed Pharmacother Biomed Pharmacother"},{"key":"905_CR36","doi-asserted-by":"publisher","unstructured":"Abdelgawad AM, El-Naggar ME, Eisa WH, Rojas OJ (2017) Clean and high-throughput production of silver nanoparticles mediated by soy protein via solid state synthesis. J Clean Prod:144. https:\/\/doi.org\/10.1016\/j.jclepro.2016.12.122","DOI":"10.1016\/j.jclepro.2016.12.122"},{"key":"905_CR37","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.jff.2017.08.011","volume":"37","author":"J Hussein","year":"2017","unstructured":"Hussein J, El-Bana M, Refaat E, El-Naggar ME (2017) Synthesis of carvacrol-based nanoemulsion for treating neurodegenerative disorders in experimental diabetes. J Funct Foods 37:441\u2013448. https:\/\/doi.org\/10.1016\/j.jff.2017.08.011","journal-title":"J Funct Foods"},{"key":"905_CR38","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1556\/JPC.26.2013.4.8","volume":"26","author":"A Al-Taweel","year":"2013","unstructured":"Al-Taweel A, Alqasoumi S, Alam P, Abdel-Kader M (2013) Densitometric-high-performance thin-layer chromatographic estimation of diosmin, hesperidin, and ascorbic acid in pharmaceutical formulations. JPC-Journal Planar Chromatogr TLC 26:336\u2013342","journal-title":"JPC-Journal Planar Chromatogr TLC"},{"key":"905_CR39","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/10408398.2010.499017","volume":"52","author":"J Xiao","year":"2012","unstructured":"Xiao J, Kai G (2012) A review of dietary polyphenol-plasma protein interactions: characterization, influence on the bioactivity, and structure-affinity relationship. Crit Rev Food Sci Nutr 52:85\u2013101","journal-title":"Crit Rev Food Sci Nutr"},{"key":"905_CR40","doi-asserted-by":"crossref","first-page":"15998","DOI":"10.1016\/j.matpr.2018.05.044","volume":"5","author":"M Giannouli","year":"2018","unstructured":"Giannouli M, Karagkiozaki V, Pappa F et al (2018) Fabrication of quercetin-loaded PLGA nanoparticles via electrohydrodynamic atomization for cardiovascular disease. Mater Today Proc 5:15998\u201316005","journal-title":"Mater Today Proc"},{"key":"905_CR41","first-page":"537","volume":"50","author":"T Szkudelski","year":"2001","unstructured":"Szkudelski T (2001) The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res 50:537\u2013546","journal-title":"Physiol Res"},{"key":"905_CR42","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3889\/oamjms.2018.477","volume":"6","author":"K Ritarwan","year":"2018","unstructured":"Ritarwan K, Lelo A, Pane YS, Nerdy N (2018) Increasing atherosclerosis in Streptozotocin-induced diabetes into four groups of mice. Open access Maced J Med Sci 6:287","journal-title":"Open access Maced J Med Sci"},{"key":"905_CR43","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cbi.2011.10.003","volume":"195","author":"S Srinivasan","year":"2012","unstructured":"Srinivasan S, Pari L (2012) Ameliorative effect of diosmin, a citrus flavonoid against streptozotocin-nicotinamide generated oxidative stress induced diabetic rats. Chem Biol Interact 195:43\u201351","journal-title":"Chem Biol Interact"},{"key":"905_CR44","doi-asserted-by":"crossref","first-page":"209","DOI":"10.4331\/wjbc.v6.i3.209","volume":"6","author":"K Husain","year":"2015","unstructured":"Husain K, Hernandez W, Ansari RA, Ferder L (2015) Inflammation, oxidative stress and renin angiotensin system in atherosclerosis. World J Biol Chem 6:209","journal-title":"World J Biol Chem"},{"key":"905_CR45","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3317\/jraas.2001.027","volume":"2","author":"DJ van Dijk","year":"2001","unstructured":"van Dijk DJ, Boner G, Giler S, Erman A (2001) Increased serum angiotensin-converting enzyme activity and plasma angiotensin II levels during pregnancy and postpartum in the diabetic rat. J Renin-Angiotensin-Aldosterone Syst 2:193\u2013198","journal-title":"J Renin-Angiotensin-Aldosterone Syst"},{"key":"905_CR46","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1124\/mol.116.104133","volume":"90","author":"Y Ogata","year":"2016","unstructured":"Ogata Y, Nemoto W, Nakagawasai O et al (2016) Involvement of spinal angiotensin II system in streptozotocin-induced diabetic neuropathic pain in mice. Mol Pharmacol 90:205\u2013213","journal-title":"Mol Pharmacol"},{"key":"905_CR47","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.fct.2018.07.027","volume":"120","author":"FEM Ali","year":"2018","unstructured":"Ali FEM, Azouz AA, Bakr AG et al (2018) Hepatoprotective effects of diosmin and\/or sildenafil against cholestatic liver cirrhosis: the role of Keap-1\/Nrf-2 and P38-MAPK\/NF-\u03baB\/iNOS signaling pathway. Food Chem Toxicol 120:294\u2013304","journal-title":"Food Chem Toxicol"},{"key":"905_CR48","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/eurheartj\/ehr112","volume":"32","author":"MJ Chapman","year":"2011","unstructured":"Chapman MJ, Ginsberg HN, Amarenco P et al (2011) Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management. Eur Heart J 32:1345\u20131361","journal-title":"Eur Heart J"},{"key":"905_CR49","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s13300-016-0167-x","volume":"7","author":"JD Schofield","year":"2016","unstructured":"Schofield JD, Liu Y, Rao-Balakrishna P et al (2016) Diabetes dyslipidemia. Diabetes Ther 7:203\u2013219","journal-title":"Diabetes Ther"},{"key":"905_CR50","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00125-003-1111-y","volume":"46","author":"M-R Taskinen","year":"2003","unstructured":"Taskinen M-R (2003) Diabetic dyslipidaemia: from basic research to clinical practice. Diabetologia 46:733\u2013749","journal-title":"Diabetologia"},{"key":"905_CR51","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ejphar.2013.08.031","volume":"718","author":"SS Queenthy","year":"2013","unstructured":"Queenthy SS, John B (2013) Diosmin exhibits anti-hyperlipidemic effects in isoproterenol induced myocardial infarcted rats. Eur J Pharmacol 718:213\u2013218","journal-title":"Eur J Pharmacol"},{"key":"905_CR52","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.biopha.2018.03.162","volume":"102","author":"R El-Fawal","year":"2018","unstructured":"El-Fawal R, El Fayoumi HM, Mahmoud MF (2018) Diosmin and crocin alleviate nephropathy in metabolic syndrome rat model: effect on oxidative stress and low grade inflammation. Biomed Pharmacother 102:930\u2013937","journal-title":"Biomed Pharmacother"},{"key":"905_CR53","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1177\/1535370216650520","volume":"242","author":"KE Petersen","year":"2017","unstructured":"Petersen KE, Lykkesfeldt J, Raun K, Rakipovski G (2017) Brief communication: plasma lipid oxidation predicts atherosclerotic status better than cholesterol in diabetic apolipoprotein E deficient mice. Exp Biol Med 242:88\u201391","journal-title":"Exp Biol Med"},{"key":"905_CR54","doi-asserted-by":"crossref","first-page":"e0119731","DOI":"10.1371\/journal.pone.0119731","volume":"10","author":"J-H Yoon","year":"2015","unstructured":"Yoon J-H, Kim J-Y, Park J-K, Ko S-B (2015) Oxidative damage markers are significantly associated with the carotid artery intima-media thickness after controlling for conventional risk factors of atherosclerosis in men. PLoS One 10:e0119731","journal-title":"PLoS One"},{"key":"905_CR55","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3164\/jcbn.2008044","volume":"43","author":"R-L Yang","year":"2008","unstructured":"Yang R-L, Shi Y-H, Hao G et al (2008) Increasing oxidative stress with progressive hyperlipidemia in human: relation between malondialdehyde and atherogenic index. J Clin Biochem Nutr 43:154\u2013158","journal-title":"J Clin Biochem Nutr"},{"key":"905_CR56","doi-asserted-by":"crossref","unstructured":"Gupta S, Sharma SB, Singh UR, Bansal SK (2011) Salutary effect of Cassia auriculata L. leaves on hyperglycemia-induced atherosclerotic environment in streptozotocin rats. Cardiovasc Toxicol 11:308","DOI":"10.1007\/s12012-011-9120-4"},{"key":"905_CR57","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.gene.2018.01.094","volume":"650","author":"P Gomathi","year":"2018","unstructured":"Gomathi P, Iyer AC, Murugan PS et al (2018) Association of paraoxonase-1 gene polymorphisms with insulin resistance in south Indian population. Gene 650:55\u201359","journal-title":"Gene"},{"key":"905_CR58","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.metabol.2017.05.004","volume":"73","author":"SK Kunutsor","year":"2017","unstructured":"Kunutsor SK, Kieneker LM, Bakker SJL et al (2017) Incident type 2 diabetes is associated with HDL, but not with its anti-oxidant constituent-paraoxonase-1: the prospective cohort PREVEND study. Metabolism 73:43\u201351","journal-title":"Metabolism"},{"key":"905_CR59","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.diabres.2018.03.055","volume":"140","author":"A Viktorinova","year":"2018","unstructured":"Viktorinova A, Jurkovicova I, Fabryova L et al (2018) Abnormalities in the relationship of paraoxonase 1 with HDL and apolipoprotein A1 and their possible connection to HDL dysfunctionality in type 2 diabetes. Diabetes Res Clin Pract 140:174\u2013182","journal-title":"Diabetes Res Clin Pract"},{"key":"905_CR60","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.jpba.2009.09.012","volume":"51","author":"MA Campanero","year":"2010","unstructured":"Campanero MA, Escolar M, Perez G et al (2010) Simultaneous determination of diosmin and diosmetin in human plasma by ion trap liquid chromatography\u2013atmospheric pressure chemical ionization tandem mass spectrometry: application to a clinical pharmacokinetic study. J Pharm Biomed Anal 51:875\u2013881","journal-title":"J Pharm Biomed Anal"},{"key":"905_CR61","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1056\/NEJM200006153422406","volume":"342","author":"HP Kohler","year":"2000","unstructured":"Kohler HP, Grant PJ (2000) Plasminogen-activator inhibitor type 1 and coronary artery disease. N Engl J Med 342:1792\u20131801","journal-title":"N Engl J Med"},{"key":"905_CR62","doi-asserted-by":"crossref","first-page":"141","DOI":"10.4236\/ojemd.2017.76013","volume":"7","author":"M Moustapha","year":"2017","unstructured":"Moustapha M, Chadhli-Chaieb M, Mahjoub T, Chaieb L (2017) Genetic and metabolic determinants of plasminogen activator inhibitor 1 (PAI-1) in Tunisian type 2 diabetes patients. Open J Endocr Metab Dis 7:141","journal-title":"Open J Endocr Metab Dis"},{"key":"905_CR63","doi-asserted-by":"crossref","unstructured":"Mahmoud AM (2017) Exercise amaliorates metabolic disturbances and oxidative stress in diabetic cardiomyopathy: possible underlying mechanisms. In: Exercise for Cardiovascular Disease Prevention and Treatment. Springer, pp 207\u2013230","DOI":"10.1007\/978-981-10-4307-9_12"},{"key":"905_CR64","doi-asserted-by":"crossref","first-page":"6680","DOI":"10.1038\/sj.onc.1209954","volume":"25","author":"TD Gilmore","year":"2006","unstructured":"Gilmore TD (2006) Introduction to NF-\u03baB: players, pathways, perspectives. Oncogene 25:6680","journal-title":"Oncogene"},{"key":"905_CR65","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1161\/hh0901.090440","volume":"88","author":"A Tedgui","year":"2001","unstructured":"Tedgui A, Mallat Z (2001) Anti-inflammatory mechanisms in the vascular wall. Circ Res 88:877\u2013887","journal-title":"Circ Res"},{"key":"905_CR66","doi-asserted-by":"crossref","first-page":"e14240","DOI":"10.1371\/journal.pone.0014240","volume":"5","author":"GV Shrikhande","year":"2010","unstructured":"Shrikhande GV, Scali ST, da Silva CG et al (2010) O-glycosylation regulates ubiquitination and degradation of the anti-inflammatory protein A20 to accelerate atherosclerosis in diabetic ApoE-null mice. PLoS One 5:e14240","journal-title":"PLoS One"},{"key":"905_CR67","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.mefs.2017.02.004","volume":"22","author":"AS Saad","year":"2017","unstructured":"Saad AS, Mohamed KAA (2017) Diosmin versus cabergoline for prevention of ovarian hyperstimulation syndrome. Middle East Fertil Soc J 22:206\u2013210","journal-title":"Middle East Fertil Soc J"},{"key":"905_CR68","first-page":"396","volume":"9","author":"H Soufy","year":"2012","unstructured":"Soufy H, Lin TS, Das S, Zakaria Z (2012) Histological changes in the heart and the proximal aorta in experimental diabetic rats fed with Piper sarmentsoum. African J Tradit Complement Altern Med 9:396\u2013404","journal-title":"African J Tradit Complement Altern Med"},{"key":"905_CR69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2840-1-1","volume":"1","author":"D Aronson","year":"2002","unstructured":"Aronson D, Rayfield EJ (2002) How hyperglycemia promotes atherosclerosis: molecular mechanisms. Cardiovasc Diabetol 1:1","journal-title":"Cardiovasc Diabetol"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-020-00905-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10637-020-00905-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-020-00905-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T23:45:09Z","timestamp":1678491909000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10637-020-00905-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,11]]},"references-count":69,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["905"],"URL":"https:\/\/doi.org\/10.1007\/s10637-020-00905-6","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,11]]},"assertion":[{"value":"16 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Hendawy OM declares that he has no conflict of interest. Mehrez E. El-Naggar declares that he has no conflict of interest. Mona El-Banna declares that he has no conflict of interest. Moustafa M. G. Fouda declares that he has no conflict of interest. Sarah I. Othman. declares that he has no conflict of interest. Ahmed A. Allam declares that he has no conflict of interest and Osama M. Morsy declares that he has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants. All applicable international, national, and\/or institutional guidelines for the care and use of animals were followed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}